Evidence map›Paper›PMID 33795831›Full record

ArticleScientific reports2021

CXCL12 enhances pregnancy outcome via improvement of endometrial receptivity in mice.

Hwa Seon Koo, Min-Ji Yoon, Seon-Hwa Hong, Jungho Ahn, Hwijae Cha, Danbi Lee, Ji-Eun Ko, Hwang Kwon, Dong Hee Choi, Kyung-Ah Lee and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Chemokines in Pregnancy.Biomolecules · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Regulation and Function of Chemokines at the Maternal-Fetal Interface.Frontiers in cell and developmental biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Hwa Seon KooCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Min-Ji YoonDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Seon-Hwa HongCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Jungho AhnDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Hwijae ChaDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Danbi LeeDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Ji-Eun KoCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Hwang KwonCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Dong Hee ChoiCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Kyung-Ah LeeDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Jung-Jae KoDepartment of Biomedical Science, School of Life Science, CHA University, Seongnam-si, Gyunggi-do, South Korea.
Youn-Jung KangCHA Fertility Center Bundang, CHA University, Seongnam-si, Gyunggi-do, South Korea. yjkang@cha.ac.kr.
CHA University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Successful pregnancy inevitably depends on the implantation of a competent embryo into a receptive endometrium. Although many substances have been suggested to improve the rate of embryo implantation targeting enhancement of endometrial receptivity, currently there rarely are effective evidence-based treatments to prevent or cure this condition. Here we strongly suggest minimally-invasive intra-uterine administration of embryo-secreted chemokine CXCL12 as an effective therapeutic intervention. Chemokine CXCL12 derived from pre- and peri-implanting embryos significantly enhances the rates of embryo attachment and promoted endothelial vessel formation and sprouting in vitro. Consistently, intra-uterine CXCL12 administration in C57BL/6 mice improved endometrial receptivity showing increased integrin β3 and its ligand osteopontin, and induced endometrial angiogenesis displaying increased numbers of vessel formation near the lining of endometrial epithelial layer with higher CD31 and CD34 expression. Furthermore, intra-uterine CXCL12 application dramatically promoted the rates of embryo implantation with no morphologically retarded embryos. Thus, our present study provides a novel evidence that improved uterine endometrial receptivity and enhanced angiogenesis induced by embryo-derived chemokine CXCL12 may aid to develop a minimally-invasive therapeutic strategy for clinical treatment or supplement for the patients with repeated implantation failure with less risk.

Indexed as

Pregnancy OutcomeAnimalsBiomarkersBirth RateCell Culture TechniquesCell LineChemokine CXCL12Embryo ImplantationEndometriumFemaleGene ExpressionGene Expression ProfilingGene OntologyHumansImmunohistochemistryMaleBiomarkersChemokine CXCL12Cmkor1 protein, mouseCxcl12 protein, mouseCXCR4 protein, mouseReceptors, CXCRReceptors, CXCR4

Identifiers

PMID33795831
PMCPMC8016928
OpenAlexW3146447220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.